関連する実験動画
Updated: Jul 8, 2026

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
調整可能な胃帯膜と2型糖尿病の従来の治療:ランダム化制御試験
John B Dixon1, Paul E O'Brien, Julie Playfair
1Centre for Obesity Research and Education, Monash University Medical School, The Alfred Hospital, Melbourne, Victoria, Australia. john.dixon@med.monash.edu.au
JAMA
|January 24, 2008
まとめ
手術による体重減少は,従来の方法と比較して,血糖コントロールと糖尿病寛解を大幅に改善します. この減量外科手術のアプローチは,肥満患者の2型糖尿病のより効果的な治療法を提供します.
科学分野:
- メタボリック外科手術
- エンドクリノロジー エンドクリノロジー
- バリアトリックの手続き
背景:
- 観察研究では,手術による体重減少が2型糖尿病の効果的な治療法である可能性があることが示されています.
- この研究は,糖尿病管理のための手術対従来の減量に関する比較データの必要性に対処しています.
研究 の 目的:
- 2型糖尿病の管理における従来の減量方法と比較して,外科的に誘発された減量 (ラパロスコープによる調整可能な胃帯) の有効性を比較する.
- 血糖コントロールの改善と糖尿病の薬剤の必要性の削減を評価する.
主な方法:
- 最近診断された2型糖尿病の肥満患者60人を対象とした無盲ランダム化対照試験.
- 介入には,生活習慣の変化に焦点を当てた従来の糖尿病治療と対比して,腹腔鏡で調整可能な胃帯状帯状が含まれていました.
- 主なアウトカムは,2型糖尿病の寛解であり,薬剤なしで特定のグルコースとHbA1cレベルによって定義されました.
主要な成果:
- 手術による介入により,2型糖尿病の寛解率は73%となり,従来の治療では13%であった.
- 外科手術を受けたグループは,通常のグループ (1.7%) と比べて,2年間で著しく大きな体重減少 (20.7%) を達成しました.
- 糖尿病の寛解は,体重減少量とHbA1cのベースラインレベルと強く相関していました.
結論:
- ラパロスコープで調整可能な胃帯は,かなりの体重減少を通じて2型糖尿病の寛解の可能性を大幅に高めます.
- 長期的な有効性と安全性を確認するために,より大規模で多様な集団でのさらなる研究が必要である.
関連する概念動画
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

